Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Avadel Pharmaceuticals (Nasdaq: AVDL) has announced the approval of inducement awards for nine new employees by its Board's Compensation Committee. The grants include non-statutory options to purchase 48,400 ordinary shares under the company's 2021 Inducement Plan.
The stock options, awarded in compliance with Nasdaq Listing Rule 5635(c)(4), feature a ten-year term and a four-year vesting schedule. The vesting structure includes 25% vesting on the first anniversary of each employee's start date, followed by additional 25% portions vesting on the second, third, and fourth anniversaries. These awards were granted as inducement material for employment acceptance and are governed by Avadel's 2021 Inducement Plan terms and specific award agreements.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha annunciato l'approvazione di premi di indennità per nove nuovi dipendenti da parte del Comitato per la Compensazione del suo Consiglio. I premi includono opzioni non statutarie per acquistare 48.400 azioni ordinarie nell'ambito del Piano di Indennità 2021 dell'azienda.
Le opzioni azionarie, assegnate in conformità con il Regolamento di Quotazione Nasdaq 5635(c)(4), presentano una durata di dieci anni e un programma di maturazione di quattro anni. La struttura di maturazione prevede il 25% di maturazione al primo anniversario della data di inizio di ciascun dipendente, seguito da ulteriori porzioni del 25% che maturano nei secondi, terzi e quarti anniversari. Questi premi sono stati concessi come incentivo per l'accettazione dell'impiego e sono regolati dai termini del Piano di Indennità 2021 di Avadel e dagli specifici accordi di premio.
Avadel Pharmaceuticals (Nasdaq: AVDL) ha anunciado la aprobación de premios de inducción para nueve nuevos empleados por parte del Comité de Compensación de su Junta. Las concesiones incluyen opciones no estatutarias para comprar 48,400 acciones ordinarias bajo el Plan de Inducción 2021 de la empresa.
Las opciones sobre acciones, otorgadas de acuerdo con la Regla de Cotización de Nasdaq 5635(c)(4), cuentan con un plazo de diez años y un cronograma de adquisición de cuatro años. La estructura de adquisición incluye un 25% de adquisición en el primer aniversario de la fecha de inicio de cada empleado, seguido de porciones adicionales del 25% que se adquieren en el segundo, tercer y cuarto aniversarios. Estos premios se otorgaron como incentivo para la aceptación del empleo y están regidos por los términos del Plan de Inducción 2021 de Avadel y los acuerdos específicos de premios.
아바델 제약 (Nasdaq: AVDL)는 이사회의 보상위원회가 아홉 명의 신입 직원에게 유인 보상 승인을 발표했다고 밝혔습니다. 이 보상에는 회사의 2021년 유인 계획에 따라 48,400주 일반 주식을 구매할 수 있는 비법정 옵션이 포함됩니다.
주식 옵션은 나스닥 상장 규칙 5635(c)(4)에 따라 부여되며, 10년의 기간과 4년의 베스팅 일정이 특징입니다. 베스팅 구조는 각 직원의 시작일 1주년 기념일에 25%가 베스팅되며, 이후 두 번째, 세 번째 및 네 번째 기념일에 추가로 25%씩 베스팅됩니다. 이러한 보상은 고용 수락을 위한 유인 자료로 제공되었으며, 아바델의 2021년 유인 계획의 조건 및 특정 보상 계약에 의해 규제됩니다.
Avadel Pharmaceuticals (Nasdaq: AVDL) a annoncé l'approbation de primes d'incitation pour neuf nouveaux employés par le Comité de Rémunération de son Conseil. Les attributions comprennent des options non statutaires pour acheter 48 400 actions ordinaires dans le cadre du Plan d'Incitation 2021 de l'entreprise.
Les options d'achat d'actions, accordées conformément à la Règle de Cotation Nasdaq 5635(c)(4), présentent une durée de dix ans et un calendrier d'acquisition de quatre ans. La structure d'acquisition prévoit 25 % d'acquisition à la première date d'anniversaire de chaque employé, suivie de portions supplémentaires de 25 % acquises aux deuxième, troisième et quatrième anniversaires. Ces primes ont été accordées comme incitation à l'acceptation de l'emploi et sont régies par les conditions du Plan d'Incitation 2021 d'Avadel et les accords spécifiques de primes.
Avadel Pharmaceuticals (Nasdaq: AVDL) hat die Genehmigung von Anreizprämien für neun neue Mitarbeiter durch den Vergütungsausschuss des Vorstands bekannt gegeben. Die Zuwendungen umfassen nicht-statutäre Optionen zum Kauf von 48.400 Stammaktien im Rahmen des Unternehmensplans für Anreizprämien 2021.
Die Aktienoptionen, die gemäß der Nasdaq-Listing-Regel 5635(c)(4) gewährt wurden, haben eine Laufzeit von zehn Jahren und einen vierjährigen Vesting-Zeitplan. Die Vesting-Struktur sieht vor, dass 25% am ersten Jahrestag des Eintritts jedes Mitarbeiters fällig werden, gefolgt von weiteren 25%-Anteilen, die am zweiten, dritten und vierten Jahrestag fällig werden. Diese Prämien wurden als Anreizmaterial für die Annahme der Beschäftigung gewährt und unterliegen den Bedingungen des Avadel-Plans für Anreizprämien 2021 sowie den spezifischen Prämienvereinbarungen.
- None.
- None.
DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to nine (9) new employees to purchase 48,400 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in accordance with Nasdaq Listing Rule 5635(c)(4). The options have a ten-year term and vest over four years, with
About Avadel Pharmaceuticals plc
Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZ™, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years and older with narcolepsy. For more information, please visit www.avadel.com.
Investor Contact:
Austin Murtagh
Precision AQ
Austin.Murtagh@precisionAQ.com
(212) 698-8696
Media Contact:
Lesley Stanley
Real Chemistry
lestanley@realchemistry.com
(609) 273-3162
FAQ
How many shares are included in Avadel's (AVDL) latest inducement awards?
What is the vesting schedule for AVDL's April 2025 inducement stock options?
What is the term length of Avadel's (AVDL) new inducement stock options?
Under which plan were AVDL's new inducement awards granted?
